Trial Profile
A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Tetomilast (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 12 May 2014 New trial record